Inflammatory caspases and inflammasomes: Master switches of inflammation

Cell Death and Differentiation

Volumn 14, Issue 1, 2007, Pages 10-22

  Martinon, F ^a,b   Tschopp, J ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL TOXIN; CASPASE; CASPASE 11; CASPASE 12; CASPASE 5; CASPASE 9; CYTOKINE; ICE PROTEASE ACTIVATING FACTO; INFLAMMASOM; INTERLEUKIN 1BETA CONVERTING ENZYME; MULTIPROTEIN COMPLEX; NAL; NEURONAL APOPTOSIS INHIBITOR PROTEI; NOD LIKE RECEPTOR; PROTEINASE;

ANTHRAX; AUTOINFLAMMATORY DISEASE; BACTERIAL INFECTION; DISEASE RESISTANCE; EMBRYO DEVELOPMENT; ENDOPLASMIC RETICULUM; ENZYME ACTIVATION; GENE EXPRESSION; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; IMMUNOREGULATION; INFECTION RESISTANCE; INFLAMMATION; INNATE IMMUNITY; MOLECULAR EVOLUTION; MOLECULAR RECOGNITION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; SEPSIS;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AMINO ACID SEQUENCE; ANIMALS; APOPTOSIS REGULATORY PROTEINS; CASPASES; ENDOPLASMIC RETICULUM; ENZYME ACTIVATION; HUMANS; IMMUNITY, NATURAL; INFLAMMATION; INTERLEUKIN-1BETA; MOLECULAR SEQUENCE DATA; MULTIPROTEIN COMPLEXES; REPRODUCTION; SEPSIS;

EID: 33845497181     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/sj.cdd.4402038     Document Type: Review

References (137)

1. Black RA, Kronheim SR, Merriam JE, March CJ, Hopp TP. A pre-aspartate-specific protease from human leukocytes that cleaves pro-interleukin-1 beta. J Biol Chem 1989; 264: 5323-5326.
2. Kostura MJ, Tocci MJ, Limjuco G, Chin J, Cameron P, Hillman AG et al. Identification of a monocyte specific pre-interleukin 1 beta convertase activity. Proc Natl Acad Sci USA 1989; 86: 5227-5231.
3. Cerretti DP, Kozlosky CJ, Mosley B, Nelson N, Van Ness K, Greenstreet TA et al. Molecular cloning of the interleukin-1 beta converting enzyme. Science 1992; 256: 97-100.
4. Thornberry NA, Bull HG, Calaycay JR, Chapman KT, Howard AD, Kostura MJ et al. A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes. Nature 1992; 356: 768-774.
5. Yuan J, Shaham S, Ledoux S, Ellis HM, Horvitz HR. The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1 beta-converting enzyme. Cell 1993; 75: 641-652.
6. Lamkanfi M, Declercq W, Kalai M, Saelens X, Vandenabeele P. Alice in caspase land. A phylogenetic analysis of caspases from worm to man. Cell Death Differ 2002; 9: 358-361.
7. Martinon F, Tschopp J. Inflammatory caspases: Linking an intracellular innate immune system to autoinflammatory diseases. Cell 2004; 117: 561-574.
8. Initial sequence of the chimpanzee genome and comparison with the human genome. Nature 2005; 437: 69-87.
9. Wang X, Grus WE, Zhang J. Gene losses during human origins. PLoS Biol 2006; 4: E52.
10. Xue Y, Daly A, Yngvadottir B, Liu M, Coop G, Kim Y et al. Spread of an inactive form of caspase-12 in humans is due to recent positive selection. Am J Hum Genet 2006; 78: 659-670.
11. Schmitz J, Owyang A, Oldham E, Song Y, Murphy E, McClanahan TK et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines, Immunity 2005; 23: 479-490.
12. Li P, Allen H, Banerjee S, Franklin S, Herzog L, Johnston C et al. Mice deficient in IL-1 beta-converting enzyme are defective in production of mature IL-1 beta and resistant to endotoxic shock. Cell 1995; 80: 401-411.
13. Kuida K, Lippke JA, Ku G, Harding MW, Livingston DJ, Su MS et al. Altered cytokine export and apoptosis in mice deficient in interleukin-1 beta converting enzyme. Science 1995; 267: 2000-2003.
14. Gu Y, Kuida K, Tsutsui H, Ku G, Hsiao K, Fleming MA et al. Activation of interferon-gamma inducing factor mediated by interleukin-1 beta converting enzyme. Science 1997; 275: 206-209.
15. Ghayur T, Banerjee S, Hugunin M, Butler D, Herzog L, Carter A et al. Caspase-1 processes IFN-gamma-inducing factor and regulates LPS-induced IFN-gamma production. Nature 1997; 386: 619-623.
16. Dinarello CA, Fantuzzi G. Interleukin-18 and host defense against infection. J Infect Dis 2003; 187: S370-384.
17. Dinarello CA. Infection, fever, and exogenous and endogenous pyrogens: some concepts have changed. J Endotoxin Res 2004; 10: 201-222.
18. Staruch MJ, Wood DD. The adjuvanticity of interleukin 1 in vivo. J Immunol 1983; 130: 2191-2194.
19. Dinarello CA, Cannon JG, Wolff SM, Bernheim HA, Beutler B, Cerami A et al. Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1. J Exp Med 1986; 163: 1433-1450.
20. Krueger JM, Majde JA. Humoral links between sleep and the immune system: research issues. Ann N Y Acad Sci 2003; 992: 9-20.
21. Samad TA, Moore KA, Sapirstein A, Billet S, Allchome A, Poole S et al. Interleukin-1beta-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity. Nature 2001; 410: 471-475.
22. Tedgui A, Mallat Z. Cytokines in atherosclerosis: Pathogenic and regulatory pathways. Physiol Rev 2006; 86: 515-581.
23. Libby P. Inflammation in atherosclerosis. Nature 2002; 420: 868-874.
24. Voronov E, Shouval DS, Krelin Y, Cagnano E, Benharroch D, Iwakura Y et al. IL-1 is required for tumor invasiveness and angiogenesis. Proc Natl Acad Sci USA 2003; 100: 2645-2650.
25. Nakao S, Kuwano T, Tsutsumi-Miyahara C, Ueda S, Kimura YN, Hamano S et al. Infiltration of COX-2-expressing macrophages is a prerequisite for IL-1 beta-induced neovascularization and tumor growth. J Clin Invest 2005; 115: 2979-2991.
26. Verbruggen G. Chondroprotective drugs in degenerative joint diseases. Rheumatology (Oxford) 2006; 45: 129-138.
27. Sjoholm A. Aspects of the involvement of interleukin-1 and nitric oxide in the pathogenesis of insulin-dependent diabetes mellitus. Cell Death Differ 1998; 5: 461-468.
28. Maedler K, Sergeev P, Ris F, Oberholzer J, Joller-Jemelka HI, Spinas GA et al. Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets. J Clin Invest 2002; 110: 851-860.
29. Lucas SM, Rothwell NJ, Gibson RM. The role of inflammation in CNS injury and disease. Br J Pharmacol 2006; 147: S232-S240.
30. Hazuda DJ, Lee JC, Young PR. The kinetics of interleukin 1 secretion from activated monocytes. Differences between interleukin 1 alpha and interleukin 1 beta. J Biol Chem 1988; 263: 8473-8479.
31. Black RA, Kronheim SR, Cantrell M, Deeley MC, March CJ, Prickett KS et al. Generation of biologically active interleukin-1 beta by proteolytic cleavage of the inactive precursor. J Biol Chem 1988; 263: 9437-9442.
32. Miller DK, Ayala JM, Egger LA, Raju SM, Yamin TT, Ding GJ et al. Purification and characterization of active human interleukin-1 beta-converting enzyme from THP.1 monocytic cells. J Biol Chem 1993; 268: 18062-18069.
33. Martinon F, Burns K, Tschopp J. The inflammasome: A molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell 2002; 10: 417-426.
34. Wang S, Miura M, Jung YK, Zhu H, Li E, Yuan J. Murine caspase-11, an ICE-interacting protease, is essential for the activation of ICE. Cell 1998; 92: 501-509.
35. Lin XY, Choi MS, Porter AG. Expression analysis of the human caspase-1 subfamily reveals specific regulation of the CASP5 gene by lipopolysaccharide and interferon-gamma. J Biol Chem 2000; 275: 39920-39926.
36. Pelletier N, Casamayor-Palleja M, De Luca K, Mondiere P, Saltel F, Jurdic P et al. The endoplasmic reticulum is a key component of the plasma cell death pathway. J Immunol 2006; 176: 1340-1347.
37. Hitomi J, Katayama T, Eguchi Y, Kudo T, Taniguchi M, Koyama Y et al. Involvement of caspase-4 in endoplasmic reticulum stress-induced apoptosis and Abeta-induced cell death. J Cell Biol 2004; 165: 347-356.
38. Obeng EA, Boise LH. Caspase-12 and caspase-4 are not required for caspase-dependent endoplasmic reticulum stress-induced apoptosis. J Biol Chem 2005; 280: 29578-29587.
39. Nakagawa T, Zhu H, Morishima N, Li E, Xu J, Yankner BA et al. Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta. Nature 2000; 403: 98-103.
40. Hetz C, Russelakis-Carneiro M, Maundrell K, Castilla J, Soto C. Caspase-12 and endoplasmic reticulum stress mediate neurotoxicity of pathological prion protein. EMBO J 2003; 22: 5435-5445.
41. Kalai M, Lamkanfi M, Denecker G, Boogmans M, Lippens S, Meeus A et al. Regulation of the expression and processing of caspase-12. J Cell Biol 2003; 162: 457-467.
42. Di Sano F, Ferraro E, Tufi R, Achsel T, Piacentini M, Cecconi F. Endoplasmic reticulum stress induces apoptosis by an apoptosome-dependent but caspase 12-independent mechanism. J Biol Chem 2006; 281: 2693-2700.
43. Saleh M, Mathison JC, Wolinski MK, Bensinger SJ, Fitzgerald P, Droin N et al. Enhanced bacterial clearance and sepsis resistance in caspase-12-deficient mice. Nature 2006; 440: 1064-1068.
44. Saleh M, Vaillancourt JP, Graham RK, Huyck M, Srinivasula SM, Alnemri ES et al. Differential modulation of endotoxin responsiveness by human caspase-12 polymorphisms. Nature 2004; 429: 75-79.
45. Barrett AJ, Rawlings ND. Evolutionary lines of cysteine peptidases. Biol Chem 2001; 382: 727-733.
46. Alnemri ES, Livingston DJ, Nicholson DW, Salvesen G, Thornberry NA, Wong WW et al. Human ICE/CED-3 protease nomenclature. Cell 1996; 87: 171.
47. Yan N, Shi Y. Mechanisms of apoptosis through structural biology. Annu Rev Cell Dev Biol 2005; 21: 35-56.
48. Tinel A, Tschopp J. The PIDDosome, a protein complex implicated in activation of caspase-2 in response to genotoxic stress. Science 2004; 304: 843-846.
49. Jiang X, Wang X. Cytochrome C-mediated apoptosis. Annu Rev Biochem 2004; 73: 87-106.
50. Peter ME, Krammer PH. The CD95(APO-1/Fas) DISC and beyond. Cell Death Differ 2003; 10: 26-35.
51. Pop C, Timmer J, Sperandio S, Salvesen GS. The apoptosome activates caspase-9 by dimerization. Mol Cell 2006; 22: 269-275.
52. Boatright KM, Renatus M, Scott FL, Sperandio S, Shin H, Pedersen IM et al. A unified model for apical caspase activation. Mol Cell 2003; 11: 529-541.
53. Werts C, Girardin SE, Philpott DJ. TIR, CARD and PYRIN: Three domains for an antimicrobial triad. Cell Death Differ 2006; 13: 798-815.
54. Martinon F, Tschopp J. NLRs join TLRs as innate sensors of pathogens. Trends Immunol 2005; 26: 447-454.
55. Inohara N, Chamaillard M, McDonald C, Nunez G. NOD-LRR proteins: Role in host-microbial interactions and inflammatory disease. Annu Rev Biochem 2005: 74: 355-383.
56. Poyet JL, Srinivasula SM, Tnani M, Razmara M, Fernandes-Alnemri T, Alnemri ES. Identification of Ipaf, a human caspase-1-activating protein related to Apaf-1. J Biol Chem 2001; 276: 28309-28313.
57. Tschopp J, Martinon F, Burns K. NALPs: A novel protein family involved in inflammation. Nat Rev Mol Cell Biol 2003; 4: 95-104.
58. Roy N, Mahadevan MS, McLean M, Shutler G, Yaraghi Z, Farahani R et al. The gene for neuronal apoptosis inhibitory protein is partially deleted in individuals with spinal muscular atrophy. Cell 1995; 80: 167-178.
59. Deveraux QL, Leo E, Stennicke HR, Welsh K, Salvesen GS, Reed JC. Cleavage of human inhibitor of apoptosis protein XIAP results in fragments with distinct specificities for caspases. EMBO J 1999; 18: 5242-5251.
60. Endrizzi MG, Hadinoto V, Growney JD, Miller W, Dietrich WF. Genomic sequence analysis of the mouse Naip gene array. Genome Res 2000; 10: 1095-1102.
61. Zamboni DS, Kobayashi KS, Kohlsdorf T, Ogura Y, Long EM, Vance RE et al. The Birc1e cytosolic pattern-recognition receptor contributes to the detection and control of Legionella pneumophila infection. Nat Immunol 2006; 7: 318-325.
62. Yamamoto M, Yaginuma K, Tsutsui H, Sagara J, Guan X, Seki E et al. ASC is essential for LPS-induced activation of procaspase-1 independently of TLR-associated signal adaptor molecules. Genes Cells 2004; 9: 1055-1067.
63. Srinivasula SM, Poyet JL, Razmara M, Datta P, Zhang Z, Alnemri ES. The PYRIN-CARD protein ASC is an activating adaptor for caspase-1. J Biol Chem 2002; 277: 21119-21122.
64. Agostini L, Martinon F, Burns K, McDermott MF, Hawkins PN, Tschopp J. NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. Immunity 2004; 20: 319-325.
65. Kobe B, Kajava AV. The leucine-rich repeat as a protein recognition motif. Curr Opin Struct Biol 2001; 11: 725-732.
66. Aganna E, Martinon F, Hawkins PN, Ross JB, Swan DC, Booth DR et al. Association of mutations in the NALP3/CIAS1/PYPAF1 gene with a broad phenotype including recurrent fever, cold sensitivity, sensorineural deafness, and AA amyloidosis. Arthritis Rheum 2002; 46: 2445-2452.
67. O'Connor Jr W, Harton JA, Zhu X, Linhoff MW, Ting JP. Cutting edge: CIAS1/cryopyrin/PYPAF1/NALP3/CATERPILLER 1.1 is an inducible inflammatory mediator with NF-kappa B suppressive properties. J Immunol 2003; 171: 6329-6333.
68. Haigis MC, Haag ES, Raines RT. Evolution of ribonuclease inhibitor by exon duplication. Mol Biol Evol 2002; 19: 959-963.
69. Dickson KA, Haigis MC, Raines RT. Ribonuclease inhibitor: Structure and function. Prog Nucleic Acid Res Mol Biol 2005; 80: 349-374.
70. Chisholm ST, Coaker G, Day B, Staskawicz BJ. Host-microbe interactions: shaping the evolution of the plant immune response. Cell 2006; 124: 803-814.
71. Holt III BF, Hubert DA, Dangl JL. Resistance gene signaling in plants - complex similarities to animal innate immunity. Curr Opin Immunol 2003; 15: 20-25.
72. Hogquist KA, Nett MA, Unanue ER, Chaplin DD. Interleukin 1 is processed and released during apoptosis. Proc Natl Acad Sci USA 1991; 88: 8485-8489.
73. Ferrari D, Pizzirani C, Adinolfi E, Lemoli RM, Curti A, Idzko M et al. The P2X7 receptor: A key player in IL-1 processing and release. J Immunol 2006; 176: 3877-3883.
74. Sanz JM, Di Virgilio F. Kinetics and mechanism of ATP-dependent IL-1 beta release from microglial cells. J Immunol 2000; 164: 4893-4898.
75. Perregaux DG, McNiff P, Laliberte R, Conklyn M, Gabel CA. ATP acts as an agonist to promote stimulus-induced secretion of IL-1 beta and IL-18 in human blood. J Immunol 2000; 165: 4615-4623.
76. Buell G, Chessell IP, Michel AD, Collo G, Salazzo M, Herren S et al. Blockade of human P2X7 receptor function with a monoclonal antibody. Blood 1998; 92: 3521-3528.
77. Labasi JM, Petrushova N, Donovan C, McCurdy S, Lira P, Payette MM et al. Absence of the P2X7 receptor alters leukocyte function and attenuates an inflammatory response. J Immunol 2002; 168: 6436-6445.
78. Solle M, Labasi J, Perregaux DG, Stam E, Petrushova N, Koller BH et al. Altered cytokine production in mice lacking P2X(7) receptors. J Biol Chem 2001; 276: 125-132.
79. Kahlenberg JM, Dubyak GR. Mechanisms of caspase-1 activation by P2X7 receptor-mediated K+ release. Am J Physiol Cell Physiol 2004; 286: C1100-1108.
80. Mariathasan S, Newton K, Monack DM, Vucic D, French DM, Lee WP et al. Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature 2004; 430: 213-218.
81. Mariathasan S, Weiss DS, Newton K, McBride J, O'Rourke K, Roose-Girma M et al. Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 2006; 440: 228-232.
82. Martinon F, Petrilli V, Mayor A, Tardivel A, Tschopp J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 20D6; 440: 237-241.
83. Sutterwala FS, Ogura Y, Szczepanik M, Lara-Tejero M, Lichtenberger GS, Grant EP et al. Critical role for NALP3/CIAS1/Cryopyrin in innate and adaptive immunity through its regulation of caspase-1. Immunity 2006; 24: 317-327.
84. Kanneganti TD, Ozoren N, Body-Malapel M, Amer A, Park JH, Franchi L et al. Bacterial RNA and small antiviral compounds activate caspase-1 through cryopyrin/Nalp3. Nature 2006; 440: 233-236.
85. Ozoren N, Masumoto J, Franchi L, Kanneganti TD, Body-Malapel M, Erturk I et al. Distinct roles of TLR2 and the adaptor ASC in IL-1beta/IL-18 secretion in response to Listeria monocytogenes. J Immunol 2006; 176: 4337-4342.
86. Dode C, Le Du N, Cuisset L, Letourneur F, Berthelot JM, Vaudour G et al. New mutations of CIAS1 that are responsible for Muckle-Wells syndrome and familial cold urticaria: A novel mutation underlies both syndromes. Am J Hum Genet 2002; 70: 1498-1506.
87. Hoffman HM, Mueller JL, Broide DH, Wanderer AA, Kolodner RD. Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome. Nat Genet 2001; 29: 301-305.
88. Hawkins PN, Lachmann HJ, McDermott MF. Interleukin-1-receptor antagonist in the Muckle-Wells syndrome. N Engl J Med 2003; 346: 2583-2584.
89. Hoffman HM, Rosengren S, Boyle DL, Cho JY, Nayar J, Mueller JL et al. Prevention of cold-associated acute inflammation in familial cold autoinflammatory syndrome by interleukin-1 receptor antagonist. Lancet 2004; 364: 1779-1785.
90. Inokuchi T, Moriwaki Y, Tsutsui H, Yamamoto A, Takahashi S, Tsutsumi Z et al. Plasma interleukin (IL)-18 (interferon-gamma-inducing factor) and other inflammatory cytokines in patients with gouty arthritis and monosodium urate monohydrate crystal-induced secretion of IL-18. Cytokine 2006; 33: 21-27.
91. Antonopoulos C, Cumberbatch M, Dearman RJ, Daniel RJ, Kimber I, Groves RW. Functional caspase-1 is required for Langerhans cell migration and optimal contact sensitization in mice. J Immunol 2001; 166: 3672-3677.
92. Shornick LP, De Togni P, Mariathasan S, Goellner J, Strauss-Schoenberger J, Karr RW et al. Mice deficient in IL-1beta manifest impaired contact hypersensitivity to trinitrochlorobenzone. J Exp Med 1996; 183: 1427-1436.
93. Matos TJ, Jaleco SP, Goncalo M, Duarte CB, Lopes MC. Release of IL-1beta via IL-1beta-converting enzyme in a skin dendritic cell line exposed to 2,4-dinitrofluorobenzene. Mediators Inflamm 2005; 2005: 131-138.
94. van der Velden AW, Velasquez M, Stambach MN. Salmonella rapidly kill dendritic cells via a caspase-1-dependent mechanism. J Immunol 2003; 171: 6742-6749.
95. Jarvelainen HA, Galmiche A, Zychlinsky A. Caspase-1 activation by Salmonella. Trends Cell Biol 2003; 13: 204-209.
96. Mariathasan S, Weiss DS, Dixit VM, Monack DM. Innate immunity against Francisella tularensis is dependent on the ASC/caspase-1 axis. J Exp Med 2005; 202: 1043-1049.
97. Gavrilin MA, Bouakl IJ, Knatz NL, Duncan MD, Hall MW, Gunn JS et al. Internalization and phagosome escape required for Francisella to induce human monocyte IL-1 beta processing and release. Proc Natl Acad Sci USA 2006; 103: 141-146.
98. Cordoba-Rodriguez R, Fang H, Lankford CS, Frucht DM. Anthrax lethal toxin rapidly activates caspase-1/ACE and induces extracellular release of interleukin (IL)-1beta and IL-18. J Biol Chem 2004; 279: 20563-20566.
99. Boyden ED, Dietrich WF. Nalp1b controls mouse macrophage susceptibility to anthrax lethal toxin. Nat Genet 2006; 38: 240-244.
100. Franchi L, Amer A, Body-Malapel M, Kanneganti TD, Ozoren N, Jagirdar R et al. Cytosolic flagellin requires Ipaf for activation of caspase-1 and interleukin 1beta in salmonella-infected macrophages. Nat Immunol 2006; 7: 576-582.
101. Miao EA, Alpuche-Aranda CM, Dors M, Clark AE, Bader MW, Miller SI et al. Cytoplasmic flagellin activates caspase-1 and secretion of interleukin 1beta via Ipaf. Nat Immunol 2006; 7: 569-575.
102. Molofsky AB, Byrne BG, Whitfield NN, Madigan CA, Fuse ET, Tateda K et al. Cytosolic recognition of flagellin by mouse macrophages restricts Legionella pneumophila infection. J Exp Med 2006; 203: 1093-1104.
103. Ran T, Zamboni DS, Roy CH, Dietrich WF, Vance RE. Flagellin-deficient Legionella mutants evade caspase-1- and Naip5-mediated macrophage immunity. PLoS Pathol 2006; 2: E18.
104. Fortier A, Diez E, Gros P. Naip5/Birc1e and susceptibility to Legionella pneumophila. Trends Microbiol 2005; 13: 328-335.
105. Tong ZB, Gold L, Pfeifer KE, Dorward H, Lee E, Bondy CA et al. Mater, a maternal effect gene required for early embryonic development in mice. Nat Genet 2000; 26: 267-268.
106. Tong ZB, Bondy CA, Zhou J, Nelson LM. A human homologue of mouse Mater, a maternal effect gene essential for early embryonic development. Hum Reprod 2002; 17: 903-911.
107. Dade S, Callebaut I, Paillisson A, Bontoux M, Dalbies-Tran R, Monget P. In silico identification and structural features of six new genes similar to MATER specifically expressed in the oocyte. Biochem Biophys Res Commun 2004; 324: 547-553.
108. Dalbies-Tran R, Papillier P, Pennetier S, Uzbekova S, Monget P. Bovine mater-like NALP9 is an oocyte marker gene. Mol Reprod Dev 2005; 71: 414-421.
109. Ponsuksili S, Brunner RM, Goldammer T, Kuhn C, Walz C, Chomdej S et al. Bovine NALP5, NALP8, and NALP9 genes: Assignment to a QTL region and the expression in adult tissues, oocytes, and preimplantation embryos. Biol Reprod 2006; 74: 577-584.
110. Hamatani T, Falco G, Carter MG, Akutsu H, Stagg CA, Sharov AA et al. Age-associated alteration of gene expression patterns in mouse oocytes. Hum Mol Genet 2004; 13: 2263-2278.
111. Horikawa M, Kirkman NJ, Mayo KE, Mulders SM, Zhou J, Bondy CA et al. The mouse germ-cell-specific leucine-rich repeat protein NALP14: A member of the NACHT nucleoside triphosphatase family. Biol Reprod 2005; 72: 879-889.
112. Roper RJ, Ma RZ, Biggins JE, Butterfield RJ, Michael SD, Tung KS et al. Interacting quantitative trait loci control loss of peripheral tolerance and susceptibility to autoimmune ovarian dysgenesis after day 3 thymectomy in mice. J Immunol 2002; 169: 1640-1646.
113. Murdoch S, Djuric U, Mazhar B, Seoud M, Khan R, Kuick R et al. Mutations in NALP7 cause recurrent hydatidiform moles and reproductive wastage in humans. Nat Genet 2006; 38: 300-302.
114. Gerard N, Caillaud M, Martoriati A, Goudet G, Lalmanach AC. The interleukin-1 system and female reproduction. J Endocrinol 2004; 180: 203-212.
115. Caillaud M, Duchamp G, Gerard N. In vivo effect of interleukin-1beta and interleukin-1RA on oocyte cytoplasmic maturation, ovulation, and early embryonic development in the mare. Reprod Biol Endocrinol 2005; 22: 3:26.
116. Takehara Y, Dharmarajan AM, Kaufman G, Wallach EE. Effect of interleukin-1 beta on ovulation in the in vitro perfused rabbit ovary. Endocrinology 1994; 134: 1788-1793.
117. Chu Z, Yuan M, Yao J, Ge X, Yuan B, Xu C et al. Promoter mutations of an essential gene for pollen development result in disease resistance in rice. Genes Dev 2006; 20: 1250-1255.
118. Holt 3rd BF, Boyes DC, Ellerstrom M, Siefers N, Wiig A, Kauffman S et al. An evolutionarily conserved mediator of plant disease resistance gone function is required for normal Arabidopsis development. Dev Cell 2002; 2: 807-817.
119. Humke EW, Shriver SK, Starovasnik MA, Fairbrother WJ, Dixit VM. ICEBERG: a novel inhibitor of interleukin-1beta generation. Cell 2000; 103: 99-111.
120. Lee SH, Stehlik C, Reed JC. Cop, a caspase recruitment domain-containing protein and inhibitor of caspase-1 activation processing. J Biol Chem 2001; 276: 34495-34500.
121. Druilhe A, Srinivasula SM, Razmara M, Ahmad M, Alnemri ES. Regulation of IL-1beta generation by Pseudo-ICE and ICEBERG, two dominant negative caspase recruitment domain proteins. Cell Death Differ 2001; 8: 649-657.
122. Lamkanfi M, Denecker G, Kalai M, D'Hondt K, Meeus A, Declercq W et al. INCA, a novel human caspase recruitment domain protein that inhibits interleukin-1beta generation. J Biol Chem 2004; 279: 51729-51738.
123. Stehlik C, Krajewska M, Welsh K, Krajewski S, Godzik A, Reed JC. The PAAD/PYRIN-only protein POP1/ASC2 is a modulator of ASC-mediated nuclear-factor-kappa B and pro-caspase-1 regulation. Biochem J 2003; 373 (Part 1): 101-113.
124. Johnston JB, Barrett JW, Nazarian SH, Goodwin M, Ricuttio D, Wang G et al. A poxvirus-encoded pyrin domain protein interacts with ASC-1 to inhibit host inflammatory and apoptotic responses to infection. Immunity 2005; 23: 587-598.
125. Benedict CA, Ware CF. Poxviruses aren't stuPYD. Immunity 2005; 23: 553-555.
126. Kastner DL. Familial Mediterranean fever: The genetics of inflammation. Hosp Pract (Minneapolis) 1998; 33: 131-146.
127. Chae JJ, Komarow HD, Cheng J, Wood G, Raben N, Liu PP et al. Targeted disruption of pyrin, the FMF protein, causes heightened sensitivity to endotoxin and a defect in macrophage apoptosis. Mol Cell 2003; 11: 591-604.
128. Reymond A, Meroni G, Fantozzi A, Merla G, Cairo S, Luzi L et al. The tripartite motif family identifies call compartments. EMBO J 2001; 20: 2140-2151.
129. Ting JP, Kastner DL, Hoffman HM. CATERPILLERs, pyrin and hereditary immunological disorders. Nat Rev Immunol 2006; 6: 183-195.
130. Munding C, Keller M, Niklaus G, Papin S, Tschopp J, Werner S et al. The estrogen-responsive B box protein: A novel enhancer of interleukin-1beta secretion. Cell Death Differ 2006; 31 (in press, doi: 10.1038/ sj.cdd.4401896).
131. Grutter C, Briand C, Capitani G, Mittl PR, Papin S, Tschopp J et al. Structure of the PRYSPRY-domain: Implications for autoinflammatory diseases. FEBS Lett 2006; 580: 99-106.
132. Yu JW, Wu J, Zhang Z, Datta P, Ibrahimi I, Taniguchi S et al. Cryopyrin and pyrin activate caspase-1, but not NF-kappaB, via ASC oligomerization. Cell Death Differ 2006; 13: 236-249.
133. Stoffman N, Magal N, Shohat T, Lotan R, Koman S, Oron A et al. Higher than expected carrier rates for familial Mediterranean fever in various Jewish ethnic groups. Eur J Hum Genet 2000; 8: 307-310.
134. Aksentijevich I, Torosyan Y, Samuels J, Centola M, Pras E, Chae JJ et al. Mutation and haplotype studies of familial Mediterranean fever reveal new ancestral relationships and evidence for a high carrier frequency with reduced penetrance in the Ashkenazi Jewish population. Am J Hum Genet 1999; 64: 949-962.
135. Schaner P, Richards N, Wadhwa A, Aksentijevich I, Kastner D, Tucker P et al. Episodic evolution of pyrin in primates: Human mutations recapitulate ancestral amino acid states. Nat Genet 2001; 27: 318-3211.
136. Shoham NG, Centola M, Mansfield E, Hull KM, Wood G, Wise CA et al. Pyrin binds the PSTPIP1/CD2BP1 protein, defining familial Mediterranean fever and PAPA syndrome as disorders in the same pathway. Proc Natl Acad Sci USA 2003; 100: 13501-13506.
137. Grosse J, Chitu V, Marquardt A, Hanke P, Schmittwolf C, Zeitlmann L et al. Mutation of mouse Mayp/Pstpip2 causes a macrophage autoinflammatory disease. Blood 2006; 107: 3350-3358.